Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,450.00
0.00 (0.00%)
At close: Jun 5, 2025, 3:30 PM KST

Kyongbo Pharmaceutical Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Other Revenue
---0--0-
Upgrade
Revenue
236,544238,556216,357196,265170,660215,285
Upgrade
Revenue Growth (YoY)
2.40%10.26%10.24%15.00%-20.73%12.30%
Upgrade
Cost of Revenue
153,155156,585153,781152,397135,929163,480
Upgrade
Gross Profit
83,38981,97162,57643,86734,73151,805
Upgrade
Selling, General & Admin
67,31562,96150,58837,58034,39832,632
Upgrade
Research & Development
5,3125,3123,6543,0775,0536,238
Upgrade
Other Operating Expenses
640.38640.38608.67586.91594.64625.78
Upgrade
Operating Expenses
75,87171,51757,03242,47541,35643,144
Upgrade
Operating Income
7,51910,4545,5451,393-6,6258,661
Upgrade
Interest Expense
-4,290-4,290-3,401-1,671-1,176-1,307
Upgrade
Interest & Investment Income
70.3270.32143.4214.4425.3573.64
Upgrade
Earnings From Equity Investments
-1,362-1,376-376.33-463.72-85.58-220.73
Upgrade
Currency Exchange Gain (Loss)
-229.62-229.62399.22-752.161,402-2,221
Upgrade
Other Non Operating Income (Expenses)
388.63410.0657.91877.72302.77-702.86
Upgrade
EBT Excluding Unusual Items
2,0975,0392,368-602.15-6,1564,283
Upgrade
Gain (Loss) on Sale of Investments
-130-130-228.13-134.66-3,8368,072
Upgrade
Gain (Loss) on Sale of Assets
-6.29-6.29-11.09121.9858.68-592.7
Upgrade
Asset Writedown
--43.11---
Upgrade
Pretax Income
1,9604,9032,172-614.83-9,93314,031
Upgrade
Income Tax Expense
-334.35263.71-802.48-1,225-2,4384,626
Upgrade
Net Income
2,2954,6392,974610.59-7,4959,404
Upgrade
Net Income to Common
2,2954,6392,974610.59-7,4959,404
Upgrade
Net Income Growth
-57.22%55.97%387.13%--77.94%
Upgrade
Shares Outstanding (Basic)
242424232424
Upgrade
Shares Outstanding (Diluted)
242424232424
Upgrade
Shares Change (YoY)
-0.33%-0.34%2.14%-1.62%-0.25%0.06%
Upgrade
EPS (Basic)
95.94194.06124.0026.00-314.00393.00
Upgrade
EPS (Diluted)
95.94194.06124.0026.00-314.00393.00
Upgrade
EPS Growth
-57.08%56.50%376.92%--77.83%
Upgrade
Free Cash Flow
-17,793-12,547-4,849-2,747461.738,739
Upgrade
Free Cash Flow Per Share
-743.88-524.85-202.15-116.9719.34365.19
Upgrade
Gross Margin
35.25%34.36%28.92%22.35%20.35%24.06%
Upgrade
Operating Margin
3.18%4.38%2.56%0.71%-3.88%4.02%
Upgrade
Profit Margin
0.97%1.94%1.38%0.31%-4.39%4.37%
Upgrade
Free Cash Flow Margin
-7.52%-5.26%-2.24%-1.40%0.27%4.06%
Upgrade
EBITDA
19,97922,86217,24413,3286,13221,249
Upgrade
EBITDA Margin
8.45%9.58%7.97%6.79%3.59%9.87%
Upgrade
D&A For EBITDA
12,46012,40811,69911,93612,75712,588
Upgrade
EBIT
7,51910,4545,5451,393-6,6258,661
Upgrade
EBIT Margin
3.18%4.38%2.56%0.71%-3.88%4.02%
Upgrade
Effective Tax Rate
-5.38%---32.97%
Upgrade
Advertising Expenses
-3,9053,6831,7554,2346,838
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.